Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-07 05:30 • The Motley Fool Positive Axe Cap view: Selective

Venice Token (VVV) has surged 1,700% in 2026 and ranks 55th among cryptocurrencies with a $1.4 billion market cap. The token provides access to Venice, a privacy-focused AI platform generating $100 million in annual revenue. While theoretically a $1,000 investment could reach $1 million in three years at current growth rates, the author cautions that sustaining 1,000% annual growth is unlikely, noting that other hyped AI cryptos like Virtuals Protocol have crashed significantly after initial rallies.

Axe note: Venice Token’s explosive rise tests the boundary between hype and sustainable growth.

2026-10-07 03:21 • The Motley Fool Positive Axe Cap view: Selective

Nvidia is approaching a $6 trillion market cap milestone, but historical analysis of past trillion-dollar milestones shows the milestone itself is not predictive of future stock performance. What matters most is earnings growth relative to valuation multiples. Nvidia's strong earnings growth (120% EPS increase last quarter) and relatively low P/E ratio of 15x suggest the stock could continue climbing if earnings growth outpaces valuation compression.

Axe note: Nvidia nears a historic market cap, but South African investors should focus on fundamentals, not the headline number.

2026-10-07 02:15 • The Motley Fool Positive Axe Cap view: Selective

As inflation concerns persist amid Middle East geopolitical tensions and rising energy prices, healthcare stocks are positioned as defensive investments. Medtronic, a turnaround story with strong dividend history and accelerating growth, appeals to value investors. Eli Lilly, a GLP-1 drug leader expanding its pipeline, offers growth potential. Both companies benefit from healthcare's historical resilience to inflation.

Axe note: Medtronic and Eli Lilly stand out as defensive plays with growth potential in a tough inflationary environment.